Abbott wraps up $310M buyout of IDEV Technologies

08/26/2013 | MassDevice.com (Boston)

Abbott has completed its purchase of IDEV Technologies for $310 million. The acquisition includes IDEV's Supera Veritas system, a self-expanding stent designed to treat patients with peripheral artery disease. The device already is available commercially in Europe, but is still undergoing FDA premarket review.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX